M. Bradley

First name
M.
Middle name
C.
Last name
Bradley
Eworuke, E., Shinde, M., Hou, L., Paterson, M. J., Jensen, P. B., Maro, J. C., et al. (2023). Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. Bmj Open, 13, e070985. http://doi.org/10.1136/bmjopen-2022-070985
View
Bradley, M. C., Hughes, C. M., Cantwell, M. M., Napolitano, G., & Murray, L. J. (2010). Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study. Br J Cancer. http://doi.org/10.1038/sj.bjc.6605636
View
Bradley, M. C., Hughes, C. M., Cantwell, M. M., & Murray, L. J. (2010). Statins and pancreatic cancer risk: a nested case-control study. Cancer Causes Control. http://doi.org/10.1007/s10552-010-9628-0
View
Bradley, M. C., Murray, L. J., Cantwell, M. M., & Hughes, C. M. (2012). Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study. Br J Cancer. http://doi.org/10.1038/bjc.2011.511
View
Bradley, M. C., Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., & Hughes, C. M. (2014). Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr. http://doi.org/10.1186/1471-2318-14-72
View
Thistle, J. E., Petrick, J. L., Yang, B., Bradley, M. C., Graubard, B. I., & McGlynn, K. A. (2018). Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer Epidemiol. http://doi.org/10.1016/j.canep.2018.06.009
View
Florio, A. A., Graubard, B. I., Yang, B., Thistle, J. E., Bradley, M. C., McGlynn, K. A., & Petrick, J. L. (2019). Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. Eur J Epidemiol. http://doi.org/10.1007/s10654-019-00526-1
View